Q3 2026 Highlights:Revenue of $237.8 millionGAAP Gross Margin of 41.0%, and Non-GAAP Gross Margin of 41.2%GAAP Operating Margin of 11.5% and Non-GAAP Operating Margin of 16.6%GAAP Diluted Earnings Per Share of $1.21,
Merger now expected to close by the end of the first quarter of 2027BEVERLY, Mass., and PLAINVIEW, N.Y., Nov. 2, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) ("Axcelis") and Veeco Instruments
BEVERLY, Mass., Oct. 27, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced the appointment of Jeroen
BEVERLY, Mass., Oct. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will release financial results for the
$35 Million Investment Will Expand Axcelis' Manufacturing Capacity and Enable the Company to Better Serve CustomersBEVERLY, Mass., Oct. 20, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading
BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the
BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the
BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35
BEVERLY, Mass., Sept. 1, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to
Q2 2026 Highlights:Revenue of $215.2 millionGAAP Gross Margin of 42.4%, and Non-GAAP Gross Margin of 42.7%GAAP Operating Margin of 9.4% and Non-GAAP Operating Margin of 14.7%GAAP Diluted Earnings Per Share of $0.75, and
BEVERLY, Mass., July 29, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to
System qualified for emerging PMIC device application requiring advanced 15 MeV implant capabilityBEVERLY, Mass., July 28, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling
BEVERLY, Mass., July 22, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the
BEVERLY, Mass., May 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to
Q1 2026 Highlights:Revenue of $199.0 millionGAAP Gross Margin of 40.5%, and Non-GAAP Gross Margin of 40.7%GAAP Operating Margin of 4.0% and Non-GAAP Operating Margin of 11.7%GAAP Diluted Earnings Per Share of $0.30, and
